false0001814215Q3--12-31http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense330001814215us-gaap:PreferredStockMember2022-12-310001814215buru:EmployeesAndConsultantsMemberus-gaap:EmployeeStockOptionMember2022-01-012022-09-300001814215us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001814215us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001814215us-gaap:EmployeeStockOptionMember2023-09-300001814215buru:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Member2023-06-300001814215us-gaap:MachineryAndEquipmentMember2022-12-310001814215buru:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001814215buru:CurtisNMaasRevocableTrustMember2023-06-160001814215us-gaap:PreferredStockMember2023-09-300001814215srt:MaximumMemberburu:NoteAndWarrantPurchaseAgreementsMemberus-gaap:PrivatePlacementMember2023-06-160001814215us-gaap:PreferredStockMember2022-06-300001814215us-gaap:RetainedEarningsMember2022-04-012022-06-300001814215buru:ConsultantsMember2023-07-012023-09-300001814215buru:CohenAndCompanyCapitalMarketsMemberburu:AmendedAndRestatedSponsorSupportAndForfeitureAgreementMember2023-01-312023-01-310001814215buru:PublicWarrantsMemberburu:RedemptionOfWarrantsWhenPricePerShareOfCommonStockEqualsOrExceeds1000Member2023-01-012023-09-300001814215buru:ConsultantsMember2022-01-012022-09-300001814215buru:ConversionRightsMemberus-gaap:SeriesAPreferredStockMemberburu:CertificateOfDesignationsMember2023-09-300001814215us-gaap:RetainedEarningsMember2023-04-012023-06-300001814215us-gaap:CostOfSalesMember2023-01-012023-09-300001814215buru:TailwindMemberus-gaap:SeriesAPreferredStockMember2023-01-310001814215us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-300001814215buru:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Member2023-07-012023-09-300001814215us-gaap:CommonStockMember2022-03-310001814215us-gaap:RetainedEarningsMember2022-12-310001814215buru:MandatoryConversionMember2023-01-012023-09-300001814215us-gaap:TransferredAtPointInTimeMember2022-01-012022-09-300001814215us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001814215us-gaap:PreferredStockMember2022-03-310001814215buru:WarrantsClassifiedAsEquityMember2022-01-012022-09-300001814215buru:CstGlobalLlcMember2023-06-160001814215us-gaap:LeaseholdImprovementsMember2022-12-310001814215buru:EunomiaLpMember2023-06-160001814215us-gaap:AdditionalPaidInCapitalMember2023-06-3000018142152022-01-012022-09-300001814215srt:AsiaMember2023-01-012023-09-300001814215us-gaap:SeriesAPreferredStockMember2023-01-310001814215country:US2023-01-012023-09-300001814215buru:PublicWarrantsMember2023-01-012023-09-300001814215buru:CommonStockWarrantMember2023-01-012023-09-300001814215buru:ServicesAgreementWithAnzuPartnersMember2023-01-012023-09-300001814215us-gaap:SeriesCPreferredStockMemberburu:LegacyNuburusMember2023-01-310001814215us-gaap:RestrictedStockUnitsRSUMemberburu:LegacyNuburusMember2023-01-300001814215buru:PublicWarrantsMemberus-gaap:CommonStockMember2023-09-300001814215buru:ConsultantsMember2023-01-012023-09-3000018142152023-01-310001814215buru:NoteAndWarrantPurchaseAgreementsMemberus-gaap:PrivatePlacementMember2023-06-160001814215country:US2023-07-012023-09-300001814215buru:LegacyNuburusMember2023-09-300001814215buru:DavidSeldinMember2023-06-162023-06-160001814215us-gaap:CommonStockMember2023-09-300001814215us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonStockMember2023-01-310001814215buru:WilsonGarling2023FamilyTrustMember2023-06-160001814215us-gaap:SellingAndMarketingExpenseMember2023-07-012023-09-300001814215buru:WarrantsClassifiedAsLiabilityMember2023-01-012023-09-300001814215us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001814215buru:LegacyNuburusMember2023-01-312023-01-310001814215buru:TailwindMemberus-gaap:CommonClassBMember2023-01-3000018142152023-11-030001814215us-gaap:PreferredStockMember2023-06-300001814215buru:NoteAndWarrantPurchaseAgreementsMember2023-01-012023-09-3000018142152022-12-310001814215srt:EuropeMember2023-01-012023-09-300001814215us-gaap:RetainedEarningsMember2022-06-300001814215us-gaap:CommonStockMember2023-03-310001814215buru:PublicWarrantsMember2023-07-012023-09-300001814215buru:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150Member2023-01-012023-09-300001814215us-gaap:AdditionalPaidInCapitalMember2022-03-310001814215country:US2022-07-012022-09-300001814215us-gaap:CostOfSalesMember2022-07-012022-09-300001814215us-gaap:CommonStockMember2023-01-310001814215us-gaap:TransferredOverTimeMember2023-01-012023-09-300001814215buru:ComputerEquipmentAndSoftwareMember2022-12-310001814215buru:WilsonSonsiniGoodrichAndRosatiMemberburu:StockPurchaseAgreementMember2023-03-100001814215us-gaap:CommonStockMemberburu:LegacyNuburusMember2023-01-310001814215us-gaap:CommonStockMember2021-12-310001814215us-gaap:AdditionalPaidInCapitalMember2022-12-310001814215buru:LegacyNuburusMemberburu:SeriesAOnePreferredStockMember2023-01-310001814215srt:MaximumMember2023-06-012023-06-300001814215us-gaap:RetainedEarningsMember2022-03-310001814215us-gaap:CostOfSalesMember2023-07-012023-09-300001814215us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001814215buru:ConversionRightsMember2023-09-300001814215us-gaap:PrivatePlacementMemberburu:AmendedAndRestatedSponsorSupportAndForfeitureAgreementMemberburu:SponsorMember2023-01-312023-01-310001814215us-gaap:CommonStockMember2023-04-012023-06-300001814215buru:LegacyNuburusMember2023-01-300001814215us-gaap:TransferredAtPointInTimeMember2023-07-012023-09-300001814215us-gaap:FurnitureAndFixturesMember2022-12-310001814215us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001814215buru:LegacyNuburusMember2023-01-310001814215us-gaap:CommonStockMember2022-01-012022-03-310001814215us-gaap:TransferredOverTimeMember2022-01-012022-09-300001814215srt:EuropeMember2022-01-012022-09-3000018142152022-03-310001814215us-gaap:CommonStockMember2023-01-312023-01-310001814215us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001814215buru:NoteAndWarrantPurchaseAgreementsMembersrt:MaximumMemberus-gaap:PrivatePlacementMember2023-06-120001814215us-gaap:RetainedEarningsMember2022-07-012022-09-300001814215buru:DavidSeldinMember2022-03-012023-01-3100018142152023-04-012023-06-300001814215us-gaap:RetainedEarningsMember2023-01-012023-03-310001814215buru:TwoThousandAndTwentyTwoPlanMember2023-09-300001814215us-gaap:ConvertibleDebtSecuritiesMember2023-01-012023-09-300001814215us-gaap:CommonStockMember2023-07-012023-09-300001814215us-gaap:CommonStockMemberburu:LincolnParkMember2023-01-310001814215us-gaap:RestrictedStockUnitsRSUMember2022-12-310001814215us-gaap:CommonStockMember2023-01-012023-09-300001814215buru:WarrantsClassifiedAsLiabilityMember2022-01-012022-09-300001814215buru:AnzuPartnersMemberus-gaap:SeriesAPreferredStockMember2023-01-310001814215us-gaap:RetainedEarningsMember2021-12-310001814215us-gaap:CommonStockMember2022-07-012022-09-300001814215buru:ServicesAgreementWithAnzuPartnersMember2022-08-302022-08-300001814215us-gaap:RetainedEarningsMember2023-03-310001814215buru:ServicesAgreementWithAnzuPartnersMember2022-08-300001814215buru:NoteAndWarrantPurchaseAgreementsMemberus-gaap:PrivatePlacementMember2023-06-122023-06-160001814215srt:EuropeMember2022-07-012022-09-300001814215us-gaap:CommonStockMemberburu:LegacyNuburusMember2023-01-300001814215us-gaap:CommonStockMember2022-04-012022-06-300001814215buru:TailwindMemberus-gaap:CommonClassBMember2023-01-3100018142152023-06-120001814215srt:AsiaMember2022-07-012022-09-300001814215us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001814215us-gaap:PreferredStockMemberburu:ServicesAgreementWithAnzuPartnersMember2022-08-300001814215us-gaap:TransferredAtPointInTimeMember2023-01-012023-09-300001814215srt:MaximumMemberburu:LincolnParkMember2023-09-300001814215buru:NautilusMaserFundLPMemberburu:AmendedAndRestatedSponsorSupportAndForfeitureAgreementMember2023-01-312023-01-310001814215buru:PublicWarrantsMemberburu:RedemptionOfWarrantsWhenPricePerShareOfCommonStockIsLessThan1800Member2023-01-012023-09-300001814215buru:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Member2023-09-3000018142152022-01-012022-03-310001814215us-gaap:TransferredOverTimeMember2023-07-012023-09-300001814215us-gaap:PrivatePlacementMemberburu:CommonStockWarrantMember2023-01-012023-09-300001814215buru:SeriesBOnePreferredStockMemberburu:LegacyNuburusMember2023-01-310001814215us-gaap:PreferredStockMember2023-03-310001814215buru:TailwindMember2023-09-300001814215us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001814215us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-3000018142152023-03-310001814215buru:PublicWarrantsMemberburu:RedemptionOfWarrantsWhenPricePerShareOfCommonStockEqualsOrExceeds1800Member2023-01-012023-09-300001814215us-gaap:AdditionalPaidInCapitalMember2022-06-300001814215us-gaap:SeriesAPreferredStockMemberburu:LegacyNuburusMember2023-01-310001814215us-gaap:GeneralAndAdministrativeExpenseMember2023-07-012023-09-300001814215buru:ComputerEquipmentAndSoftwareMember2023-09-300001814215buru:DavidSeldinMember2023-06-160001814215buru:ConversionRightsMemberburu:CertificateOfDesignationsMember2023-09-300001814215us-gaap:CostOfSalesMember2022-01-012022-09-3000018142152022-09-300001814215us-gaap:EmployeeStockOptionMember2023-01-012023-09-3000018142152022-03-012023-01-310001814215buru:ConversionRightsMember2023-01-012023-09-300001814215us-gaap:RetainedEarningsMember2022-01-012022-03-310001814215us-gaap:SellingAndMarketingExpenseMember2022-07-012022-09-300001814215buru:LincolnParkMember2023-01-012023-09-300001814215buru:NoteAndWarrantPurchaseAgreementsMember2023-06-122023-06-1600018142152022-07-012022-09-300001814215buru:DavidSeldinMember2023-01-310001814215us-gaap:MachineryAndEquipmentMember2023-09-3000018142152023-09-300001814215buru:PurchaseAgreementMemberburu:LincolnParkMember2023-01-312023-01-310001814215us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001814215buru:AkeAlmgrenMember2023-01-310001814215us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-3000018142152022-04-012022-06-300001814215buru:WarrantsClassifiedAsEquityMember2023-01-012023-09-3000018142152023-06-160001814215us-gaap:AdditionalPaidInCapitalMember2023-03-310001814215us-gaap:PreferredStockMember2022-01-012022-03-310001814215buru:NoteAndWarrantPurchaseAgreementsMemberus-gaap:PrivatePlacementMember2023-06-120001814215buru:IfConvertedCommonStockFromSeriesAPreferredStockMember2023-01-012023-09-300001814215srt:MaximumMemberburu:PurchaseAgreementMemberburu:LincolnParkMember2023-01-310001814215us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001814215us-gaap:RetainedEarningsMember2023-07-012023-09-300001814215us-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-09-300001814215buru:CurtisNMaasRevocableTrustMember2023-01-310001814215srt:AsiaMember2022-01-012022-09-300001814215buru:EmployeesAndConsultantsMemberus-gaap:EmployeeStockOptionMember2023-01-012023-09-3000018142152023-06-300001814215us-gaap:CommonStockMember2022-03-012023-01-310001814215us-gaap:PreferredStockMember2022-09-300001814215srt:OfficeBuildingMemberstpr:CO2023-09-300001814215buru:EmployeeStockPurchasePlanMember2023-09-300001814215us-gaap:CommonStockMember2023-06-300001814215buru:AmendedAndRestatedSponsorSupportAndForfeitureAgreementMember2023-01-310001814215country:US2022-01-012022-09-300001814215us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100018142152021-12-310001814215us-gaap:SeriesAPreferredStockMember2023-09-300001814215us-gaap:CommonStockMember2022-09-300001814215us-gaap:TransferredAtPointInTimeMember2022-07-012022-09-300001814215buru:RonNicolMember2023-01-3100018142152023-01-012023-03-310001814215us-gaap:SeriesAPreferredStockMember2023-01-312023-01-310001814215us-gaap:AdditionalPaidInCapitalMember2021-12-310001814215buru:PublicWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001814215buru:TailwindMemberburu:AmendedAndRestatedSponsorSupportAndForfeitureAgreementMemberus-gaap:CommonClassBMember2023-01-312023-01-3100018142152022-01-012022-12-310001814215us-gaap:RestrictedStockUnitsRSUMember2023-09-300001814215us-gaap:RetainedEarningsMember2023-06-300001814215buru:PublicWarrantsMember2023-09-300001814215us-gaap:RetainedEarningsMember2023-09-300001814215us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001814215us-gaap:AdditionalPaidInCapitalMember2023-09-300001814215buru:IfConvertedCommonStockFromConvertibleNotesMember2023-01-012023-09-300001814215us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001814215buru:TailwindMemberus-gaap:CommonStockMember2023-01-300001814215srt:MaximumMember2023-01-012023-09-300001814215us-gaap:SeriesCPreferredStockMemberburu:LegacyNuburusMember2021-12-012022-01-310001814215us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-09-300001814215us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001814215us-gaap:CommonStockMember2023-01-012023-03-3100018142152022-06-3000018142152023-06-012023-06-300001814215buru:LegacyNuburusMemberus-gaap:SeriesBPreferredStockMember2023-01-310001814215buru:PublicWarrantsMember2023-01-310001814215buru:AmendedAndRestatedSponsorSupportAndForfeitureAgreementMemberus-gaap:SeriesAPreferredStockMember2023-01-310001814215us-gaap:SellingAndMarketingExpenseMember2023-01-012023-09-300001814215us-gaap:RetainedEarningsMember2022-09-300001814215us-gaap:PreferredStockMember2023-01-012023-03-310001814215us-gaap:SellingAndMarketingExpenseMember2022-01-012022-09-300001814215buru:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Member2023-01-012023-09-300001814215us-gaap:CommonStockMember2022-06-300001814215buru:CstGlobalLlcMember2023-01-310001814215us-gaap:SeriesAPreferredStockMember2022-12-310001814215buru:NoteAndWarrantPurchaseAgreementsMember2023-09-300001814215us-gaap:CommonStockMember2022-12-310001814215us-gaap:PreferredStockMember2021-12-310001814215us-gaap:LeaseholdImprovementsMember2023-09-300001814215us-gaap:CommonStockMemberburu:LegacyNuburusMember2022-03-012023-01-310001814215us-gaap:AdditionalPaidInCapitalMember2022-09-3000018142152023-01-012023-09-300001814215buru:DavidSeldinMember2023-06-122023-06-120001814215srt:MinimumMember2023-01-012023-09-300001814215buru:WGInvestmentLlcMember2023-01-310001814215us-gaap:GeneralAndAdministrativeExpenseMember2022-07-012022-09-300001814215buru:ConsultantsMember2022-07-012022-09-300001814215srt:EuropeMember2023-07-012023-09-300001814215us-gaap:TransferredOverTimeMember2022-07-012022-09-3000018142152023-07-012023-09-300001814215srt:AsiaMember2023-07-012023-09-300001814215buru:AmendedAndRestatedSponsorSupportAndForfeitureAgreementMember2023-01-312023-01-310001814215us-gaap:FurnitureAndFixturesMember2023-09-300001814215srt:OfficeBuildingMemberstpr:CO2023-01-012023-09-30xbrli:pureutr:sqftxbrli:sharesburu:Daysiso4217:USDiso4217:USDxbrli:shares
Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-39489

 

NUBURU, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

85-1288435

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

7442 S Tucson Way, Suite 130,

Centennial, CO

80112

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (720) 767-1400

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

BURU

 

NYSE American

Redeemable warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

 

BURU WS

 

NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

 

 

 

 

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of November 3, 2023, the registrant had 35,570,461 shares of common stock, $0.0001 par value per share, outstanding.

 

 

 


Table of Contents

NUBURU, INC.

FORM 10-Q

TABLE OF CONTENTS

 

 

 

Page

PART 1 – INTERIM FINANCIAL INFORMATION

 

 

 

 

 

Cautionary note regarding forward-looking statements

3

 

 

 

Item 1.

Unaudited Condensed Consolidated Financial Statements

5

 

 

 

 

Condensed Consolidated Balance Sheets

5

 

 

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

6

 

 

 

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)

7

 

 

 

Condensed Consolidated Statements of Cash Flows

9

 

 

 

Notes to Condensed Consolidated Financial Statements

10

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

23

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

32

 

 

Item 4.

Controls and Procedures

32

 

 

PART II – OTHER INFORMATION

33

 

 

Item 1.

Legal Proceedings

33

 

 

Item 1A.

Risk Factors

33

 

 

Item 2.

Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

33

 

 

Item 3.

Defaults Upon Senior Securities

33

 

 

Item 4.

Mine Safety Disclosures

33

 

 

Item 5.

Other Information

33

 

 

Item 6.

Exhibits

34

 

 

SIGNATURES

 

35

 


Table of Contents

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this "Quarterly Report") contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which statements involve substantial risk and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements contained in this Quarterly Report include, but are not limited to, statements about:

our success in retaining or recruiting, or changes required in, our officers, key employees or directors;
our public securities’ potential liquidity and trading;
the ability to maintain the listing of our common stock, par value $0.0001 par value per share (the “Common Stock”), or the 16,710,785 whole warrants of the Company sold to public investors in the IPO as part of the units (the “Public Warrants”) on a securities exchange;
the anticipated benefits of the Business Combination;
the outcome of any legal proceedings that may be instituted against us related to the Business Combination;
existing regulations and regulatory developments in the United States and other jurisdictions;
the need to hire additional personnel and our ability to attract and retain such personnel;
our plans and ability to obtain, maintain, enforce, or protect intellectual property rights;
our ability to obtain additional financing, including under that certain Purchase Agreement by and among the Company, Legacy Nuburu and Lincoln Park Capital Fund, LLC (“Lincoln Park”), dated as of August 5, 2022 (as it may be amended, supplemented or otherwise modified from time to time, the “Lincoln Park Purchase Agreement”);
the impact of the COVID-19 pandemic, including any mutations or variants thereof, and its effect on business and financial conditions;
our business, operations and financial performance, including:
expectations with respect to financial and business performance, including financial projections and business metrics and any underlying assumptions thereunder;
future business plans and growth opportunities, including revenue opportunity available from new or existing clients and expectations regarding the use of blue laser technology in 3D printing applications;
expectations regarding product development and pipeline;
expectations regarding research and development efforts;
expectations regarding market size;
expectations regarding the competitive landscape;
expectations regarding future acquisitions, partnerships or other relationships with third parties; and
future capital requirements and sources and uses of cash, including the ability to obtain additional capital in the future.

Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. The forward-looking statements contained in this Quarterly Report are based on our current expectations and beliefs concerning future developments and their potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors under the heading "Risk Factors" in the Quarterly Report and in our Annual Report on Form 10-K for the year ended December 31, 2022 (our "Annual Report") as well as the following important factors:

our inability to obtain financing, including under the Lincoln Park Purchase Agreement;
our inability to protect our intellectual property;
whether the market embraces our products;
whether we achieve full commercialization in a timely manner;
the outcome of any legal proceedings that may be instituted against us;
our ability to meet NYSE American’s continued listing standards;

3


Table of Contents

 

the inability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, our ability to grow and manage growth profitably, maintain relationships with customers and suppliers and retain our management and key employees;
our ability to retain or recruit key employees;
costs related to being a public company;
changes in applicable laws or regulations;
the possibility that we may be adversely affected by economic, business or competitive factors;
the impact of the COVID-19 pandemic, including any mutations or variants thereof, and its effect on business and financial conditions;
volatility in the financial sector and markets caused by geopolitical and economic factors; and
other risks and uncertainties set forth under the heading “Risk Factors” in Part II, Item 1A and elsewhere in this Quarterly Report and our Annual Report.

Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Frequently Used Terms

Unless otherwise stated in Item 1. Financial Statements and accompanying footnotes, or the context otherwise requires, references in this Quarterly Report to:

“Business Combination” are to the business combination of Legacy Nuburu with a subsidiary of Tailwind, with Legacy Nuburu surviving such business combination as a wholly owned subsidiary of Tailwind;

“Business Combination Agreement” are to that certain Business Combination Agreement, dated as of August 5, 2022, by and among Tailwind, Nuburu and Merger Sub, Inc., as the same has been or may be amended, modified, supplemented or waived from time to time;

“Closing” are to the consummation of the Transactions;

“Closing Date” are to January 31, 2023, the date on which the Transactions were consummated;

“Exchange Ratios” are to the quotients as defined in, and calculated in accordance with, the Business Combination Agreement, which was included as an exhibit to our Current Report on Form 8-K (File No. 001-39489) filed with the SEC on February 6, 2023;

“Legacy Nuburu” are to Nuburu Subsidiary, Inc., a Delaware corporation (f/k/a Nuburu, Inc. before the Closing Date);

“Tailwind” are to Tailwind Acquisition Corp, a Delaware corporation and our predecessor company prior to the consummation of the Transactions, which changed its name to Nuburu, Inc. following the consummation of the Transactions, and its consolidated subsidiaries;

“Tailwind IPO” are to the initial public offering by Tailwind which closed on September 9, 2020; and

“Transactions” are to the Business Combination, together with the other transactions contemplated by the Business Combination Agreement and the related agreements.

Unless the context otherwise requires, all references in this section to “Nuburu,” the “Company,” “we,” “us,” “our,” and other similar terms refer to: (i) Legacy Nuburu and its subsidiaries prior to the Closing, and (ii) Nuburu, Inc., a Delaware corporation, and its consolidated subsidiary, Nuburu Subsidiary, Inc., after the Closing.

4


Table of Contents

 

PART 1 – FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

NUBURU, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

September 30,
2023

 

 

December 31,
2022

 

 

(Unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

1,626,730

 

 

$

2,880,254

 

Accounts receivable, net

 

 

469,904

 

 

 

327,200

 

Inventories, net of allowance of $1,047,830 and $292,990, respectively

 

 

1,086,741

 

 

 

972,695

 

Deferred financing costs

 

 

65,000

 

 

 

4,258,515

 

Prepaid expenses and other current assets

 

 

579,244

 

 

 

46,737

 

Total current assets

 

 

3,827,619

 

 

 

8,485,401

 

Property and equipment, net

 

 

4,763,058

 

 

 

3,771,849

 

Construction in progress

 

 

59,672

 

 

 

188,912

 

Right-of-use assets

 

 

410,188

 

 

 

641,651

 

Other assets

 

 

34,359

 

 

 

34,359

 

TOTAL ASSETS

 

$

9,094,896

 

 

$

13,122,172

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable

 

$

4,184,347

 

 

$

4,456,587

 

Accrued expenses

 

 

1,669,842

 

 

 

2,312,118

 

Current portion of operating lease liability

 

 

366,033

 

 

 

343,049

 

Contract liabilities

 

 

230,075

 

 

 

178,750

 

Current portion of convertible notes payable

 

 

 

 

 

7,300,000

 

Total current liabilities

 

 

6,450,297

 

 

 

14,590,504

 

Operating lease liability

 

 

95,409

 

 

 

373,907

 

Convertible notes payable

 

 

6,713,241

 

 

 

 

Warrant liabilities

 

 

334,216

 

 

 

 

TOTAL LIABILITIES

 

 

13,593,163

 

 

 

14,964,411

 

Commitments and Contingencies (Note 6)

 

 

 

 

 

 

Stockholders’ Equity (Deficit)

 

 

 

 

 

 

Convertible preferred stock, $0.0001 par value; 50,000,000 shares authorized; 3,038,905 and 23,237,703 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

 

 

304

 

 

 

4,040

 

Common stock, $0.0001 par value; 250,000,000 shares authorized; 35,554,624 and 5,556,857 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

 

 

3,555

 

 

 

1,077

 

Additional paid-in capital

 

 

72,649,712

 

 

 

59,344,952

 

Accumulated deficit

 

 

(77,151,838

)

 

 

(61,192,308

)

Total Stockholders’ Equity (Deficit)

 

 

(4,498,267

)

 

 

(1,842,239

)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

$

9,094,896

 

 

$

13,122,172

 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

5


Table of Contents

 

NUBURU, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Revenue

$

186,743

 

$

868,153

 

$

1,710,794

 

 

$

1,005,528

 

Cost of revenue

 

 

1,115,703

 

 

 

1,832,036

 

 

 

4,813,404

 

 

 

3,653,980

 

Gross margin

 

(928,960

)

 

(963,883

)

 

(3,102,610

)

 

 

(2,648,452

)

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

1,348,450

 

 

1,066,161

 

 

4,300,166

 

 

 

2,684,694

 

Selling and marketing

 

 

523,627

 

 

 

95,670

 

 

 

1,066,289

 

 

 

603,629

 

General and administrative

 

2,335,605

 

 

1,757,104

 

 

8,409,877

 

 

 

4,131,477

 

Total operating expenses

 

4,207,682

 

 

2,918,935

 

 

13,776,332

 

 

 

7,419,800

 

Loss from operations

 

 

(5,136,642

)

 

 

(3,882,818

)

 

 

(16,878,942

)

 

 

(10,068,252

)

Interest income

 

 

46,998

 

 

 

14,875

 

 

 

91,914

 

 

 

19,178

 

Interest expense

 

 

(162,765

)

 

 

(55,276

)

 

 

(175,149

)

 

 

(57,490

)

Other income, net

 

167,108

 

 

 

 

1,002,647

 

 

 

 

Loss before provision for income taxes

 

$

(5,085,301

)

 

$

(3,923,219

)

 

$

(15,959,530

)

 

$

(10,106,564

)

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

Net loss and comprehensive loss

$

(5,085,301

)

$

(3,923,219

)

$

(15,959,530

)

 

$

(10,106,564

)

Net loss per share, basic and diluted

$

(0.14

)

$

(0.71

)

$

(0.50

)

 

$

(1.86

)

Weighted-average common shares used to compute net loss per share attributable to common stockholders, basic and diluted

 

35,425,105

 

 

5,537,557

 

 

31,955,539

 

 

 

5,421,056

 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

6


Table of Contents

 

NUBURU, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

(UNAUDITED)

 

Convertible
Preferred Stock

 

Common Stock

 

 

 

 

 

 

 

 

 

 

Shares(1)

 

 

Amount

 

 

Shares(1)

 

 

Amount

 

 

Additional
Paid-in
Capital

 

 

Accumulated
Deficit

 

 

Total
Stockholders'
Equity
(Deficit)

 

Balance as of December 31, 2022

 

 

23,237,703

 

$

4,040

 

 

5,556,857

 

$

1,077

 

$

59,344,952

 

$

(61,192,308

)

$

(1,842,239

)

Issuance of Common Stock and Series A preferred stock upon conversion of convertible notes in connection with the reverse recapitalization

 

 

1,361,787

 

 

 

136

 

 

 

1,361,787

 

 

 

136

 

 

 

11,575,014

 

 

 

 

 

 

11,575,286

 

Conversion of Legacy Nuburu convertible preferred stock into Common Stock in connection with the reverse recapitalization

 

 

(23,237,703

)

 

 

(4,040

)

 

 

23,237,703

 

 

 

2,323

 

 

 

1,717

 

 

 

 

 

 

 

Issuance of Common Stock and Series A preferred stock upon the reverse recapitalization, net of issuance costs

 

 

1,481,666

 

 

 

148

 

 

 

3,233,745

 

 

 

(197

)

 

 

(3,257,476

)

 

 

 

 

 

(3,257,525

)

Issuance of Common Stock and Series A preferred stock to satisfy certain reverse recapitalization costs

 

 

195,452

 

 

 

20

 

 

 

195,452

 

 

 

20

 

 

 

(40

)

 

 

 

 

 

 

Recognition of Public Warrants upon the reverse recapitalization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,336,863

)

 

 

 

 

 

(1,336,863

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

463,978

 

 

 

 

 

 

463,978

 

Net loss

 

 

 

 ​

 

 

 ​

 

 

 ​

 

 

 ​

 

 

 ​

 

(4,767,517

)

 ​

 

(4,767,517

)

Balance as of March 31, 2023

 

3,038,905

 

$

304

 

 

33,585,544

 

$

3,359

 

$

66,791,282

 

$

(65,959,825

)

$

835,120

 

Issuance of Common Stock from option exercises

 

 

 

 

 

 

 

 

5,153

 

 

 

1

 

 

 

6,998

 

 

 

 

 

 

6,999

 

Issuance of Common Stock from releases of restricted stock units

 

 

 

 

 

 

 

 

15,625

 

 

 

2

 

 

 

(2

)

 

 

 

 

 

 

Issuance of Common Stock from the Lincoln Park Purchase Agreement

 

 

 

 

 

 

 

 

1,681,898

 

 

 

167

 

 

 

2,099,830

 

 

 

 

 

 

2,099,997

 

Issuance of Common Stock warrants in connection with the 2023 Note and Warrant Purchase Agreement (net of issuance cost of $160,345)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,351,414

 

 

 

 

 

 

2,351,414

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

796,783

 

 

 

 

 

 

796,783

 

Net loss

 

 

 

 ​

 

 

 ​

 

 

 ​

 

 

 ​

 

 

 ​

 

(6,106,712

)

 ​

 

(6,106,712

)

Balance as of June 30, 2023

 

3,038,905

 

$

304

 

 

35,288,220

 

$

3,529

 

$

72,046,305

 

$

(72,066,537

)

$

(16,399

)

Issuance of Common Stock from releases of restricted stock units

 

 

 

 

 

 

 

 

326,579

 

 

 

32

 

 

 

(32

)

 

 

 

 

 

 

Restricted stock units used for tax withholdings

 

 

 

 

 

 

 

 

(60,175

)

 

 

(6

)

 

 

(31,589

)

 

 

 

 

 

(31,595

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

635,028

 

 

 

 

 

 

635,028

 

Net loss

 

 

 

 ​

 

 

 ​

 

 

 ​

 

 

 ​

 

 

 ​

 

(5,085,301

)

 ​

 

(5,085,301

)

Balance as of September 30, 2023

 

3,038,905

 

$

304

 

 

35,554,624

 

$

3,555

 

$

72,649,712

 

$

(77,151,838

)

$

(4,498,267

)

 

7


Table of Contents

 

Convertible
Preferred Stock

 

Common Stock

 

 

 

 

 

 

 

 

 

Shares(1)

 

 

Amount

 

 

Shares(1)

 

 

Amount

 

 

Additional
Paid-in
Capital

 

 

Accumulated
Deficit

 

 

Total
Stockholders'
Equity
(Deficit)

 

Balance as of December 31, 2021

 

 

23,196,296

 

$

4,036

 

 

 

5,153,286

 

$

999

 

$

56,646,247

 

$

(47,063,207

)

$

9,588,075

 

Issuance of Legacy Nuburu Series C preferred stock

 

 

41,407

 

 

 

4

 

 

 

 

 

 

 

 

 

188,886

 

 

 

 

 

 

188,890

 

Issuance of Legacy Nuburu common stock from option exercises

 

 

 

 

 

 

 

 

370,395

 

 

 

72

 

 

 

107,788

 

 

 

 

 

 

107,860

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

69,455

 

 

 

 

 

 

69,455

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(2,287,794

)

 

(2,287,794

)

Balance as of March 31, 2022

 

23,237,703

 

$

4,040

 

 

5,523,681

 

$

1,071

 

$

57,012,376

 

$

(49,351,001

)

$

7,666,486

 

Issuance of Legacy Nuburu common stock from option exercises

 

 

 

 

 

 

 

 

1,396

 

 

 

 

 

 

6,066

 

 

 

 

 

 

6,066

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,197,233

 

 

 

 

 

 

1,197,233

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(3,895,551

)

 

(3,895,551

)

Balance as of June 30, 2022

 

23,237,703

 

$

4,040

 

 

5,525,077

 

$

1,071

 

$

58,215,675

 

$

(53,246,552

)

$

4,974,234

 

Issuance of Legacy Nuburu common stock from option exercises

 

 

 

 

 

 

 

 

25,770

 

 

 

5

 

 

 

7,495

 

 

 

 

 

 

7,500

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

600,160

 

 

 

 

 

 

600,160

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(3,923,219

)

 

(3,923,219

)

Balance as of September 30, 2022

 

23,237,703

 

$

4,040

 

 

5,550,847

 

$

1,076

 

$

58,823,330

 

$

(57,169,771

)

$

1,658,675

 

(1) The number of shares of convertible preferred stock and common stock issued and outstanding prior to the Business Combination have been retroactively adjusted by the Exchange Ratio to give effect to the reverse recapitalization treatment of the Business Combination. See Note 1 - Description of Business and Note 3 - Reverse Capitalization for more information.

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

8


Table of Contents

 

NUBURU, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

Nine Months Ended
September 30,

 

 

2023

 

 

2022

 

Cash Flows from Operating Activities:

 

 

 

Net loss

$

(15,959,530

)

$

(10,106,564

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

Depreciation and amortization

 

369,971

 

 

380,539

 

Stock-based compensation

 

1,895,789

 

 

1,866,848

 

Change in fair value of warrant liabilities

 

 

(1,002,647

)

 

 

 

Excess and obsolete inventory reserve adjustments

 

 

868,002

 

 

 

269,893

 

Inventory lower of cost and net realizable value adjustments

 

 

(113,162

)

 

 

(548,190

)

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

(142,704

)

 

(520,450

)

Inventories

 

(957,916

)

 

(381,503

)

Prepaid expenses and other current assets

 

 

(492,507

)

 

 

(13,181

)

Operating lease right-of-use asset

 

 

231,463

 

 

 

218,076

 

Accounts payable

 

2,695,273

 

 

1,107,378

 

Accrued expenses

 

 

(447,024

)

 

 

587,103</